Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.39 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | GPBAR1 | Q8TDU6 | 2/20 | 0.38 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.38 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.38 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1396371 | 0.95 | LTA4H (0.41) | L3MBTL1TDP1GAALTA4HCYP1A2 | |
| SCHEMBL2458064 | 0.93 | MCHR1 (0.41) | L3MBTL1TDP1GAALTA4HMCHR1 | |
| SCHEMBL2456698 | 0.93 | MCHR1 (0.41) | L3MBTL1TDP1GAALTA4HMCHR1 | |
| SCHEMBL6283599 | 0.93 | MCHR1 (0.41) | L3MBTL1TDP1GAALTA4HMCHR1 | |
| SCHEMBL1389283 | 0.91 | TLR8 (0.37) | L3MBTL1TDP1GAALTA4HMCHR1 | |
| SCHEMBL2253966 | 0.85 | LTA4H (0.41) | L3MBTL1TDP1GAALTA4HCYP1A2 | |
| SCHEMBL64412 | 0.84 | ALDH1A1 (0.34) | L3MBTL1TDP1GAALTA4HCYP1A2 | |
| SCHEMBL2456166 | 0.83 | NCF1 (0.41) | L3MBTL1TDP1KDM4ENPC1ALDH1A1 | |
| SCHEMBL2214684 | 0.83 | TSHR (0.39) | TDP1KDM4EALDH1A1HPGDTSHR | |
| SCHEMBL20694959 | 0.81 | GPBAR1 (0.43) | LTA4HMCHR1TLR8NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-3993645-A | Stilbene optical brighteners and compositions brightened therewith | STERLING DRUG INC. (US) | 1976-11-23 | — | — | US | claimed |
| US-3932301-A | NYLON, POLYESTERS | STERLING DRUG INC. (US) | 1976-01-13 | — | — | US | claimed |
| CN-118160125-A | Electrolyte, sodium ion secondary battery, battery module, battery pack, and electricity using device | 宁德时代新能源科技股份有限公司 | 2024-06-07 | — | — | CN | disclosed |
| WO-2023245331-A1 | ELECTROLYTE, SODIUM ION SECONDARY BATTERY, BATTERY MODULE, BATTERY PACK, AND ELECTRIC APPARATUS | 宁德时代新能源科技股份有限公司 | 2023-12-28 | — | — | WO | disclosed |
| EP-3559152-A1 | OPTICAL MEDIUM AND AN OPTICAL DEVICE | Merck Patent GmbH (DE) | 2019-10-30 | — | — | EP | disclosed |
| US-10234757-B2 | Polymer, making method, resist composition, and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2019-03-19 | — | — | US | disclosed |
| EP-2664633-B1 | POLYMER, MAKING METHOD, RESIST COMPOSITION, AND PATTERNING PROCESS | SHINETSU CHEMICAL CO (JP) | 2018-11-07 | — | — | EP | disclosed |
| WO-2018114761-A1 | OPTICAL MEDIUM AND AN OPTICAL DEVICE | MERCK PATENT GMBH (DE) | 2018-06-28 | — | — | WO | disclosed |
| EP-2514402-B1 | PREVENTING OR AMELIORATING AGENT FOR PIGMENTATION | POLA CHEM IND INC (JP) | 2016-08-31 | — | — | EP | disclosed |
| US-9414998-B2 | Preventing or ameliorating agent for pigmentation | POLA CHEMICAL INDUSTRIES INC. (JP) | 2016-08-16 | — | — | US | disclosed |
| US-8980527-B2 | Pattern forming process and resist compostion | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2015-03-17 | — | — | US | disclosed |
| WO-2004028538-A1 | SMALL ORGANIC MOLECULES THAT INCREASE THE ACTIVITY OF GELATINASE A IN OCULAR CELLS | BAUSCH & LOMB INCORPORATED (US) | 2004-04-08 | — | — | WO | disclosed |
| US-20040068017-A1 | Small organic molecules that increase the activity of Gelatinase A in ocular cells | BAUSCH & LOMB INCORPORATED | 2004-04-08 | — | — | US | disclosed |
| US-5811081-A | Use of hydroxybenzotriazoles for enhancing the sun protection factor of cellulosic fibre materials | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1998-09-22 | — | — | US | disclosed |
| EP-0708197-A2 | Utilisation of hydroxybenztriazoles for increasing the sun-ray filter index of fibrous cellulosic materials | CIBA-GEIGY AG (CH) | 1996-04-24 | — | — | EP | disclosed |
| US-4279720-A | PHENYLGLYOXYLATE PHOTOINITIATOR WITH POLYALKYLPIPERIDINE STABILIZER | CIBA-GEIGY CORPORATION (US) | 1981-07-21 | — | — | US | disclosed |
| EP-0007059-B1 | PHOTOCURABLE COMPOSITIONS | CIBA-GEIGY AG (CH) | 1981-04-15 | — | — | EP | disclosed |
| EP-0007059-A1 | Photocurable compositions | CIBA-GEIGY AG (CH) | 1980-01-23 | — | — | EP | disclosed |
| US-3993645-A | Stilbene optical brighteners and compositions brightened therewith | STERLING DRUG INC. (US) | 1976-11-23 | — | — | US | disclosed |
| US-3932301-A | NYLON, POLYESTERS | STERLING DRUG INC. (US) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040068017-A1 | Small organic molecules that increase the activity of Gelatinase A in ocular cells | MMP1, MMP3, MMP10 | L3MBTL1 4762/4885TDP1 2302/4885GAA 165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.